I3: ECOSYSTEM of NEUROMODULATION: Real World Data (RWD) and Real World Evidence (RWE)

8:00 AM - 5:00 PM Thursday, Jan. 12

The Annual North American Neuromodulation Society (NANS) Invention, Investment, and Invigoration (I3) Forum is designed to provide a dynamic and interactive platform for the review and discussion of emerging topics, technologies, clinical applications, and socioeconomic issues. Clinicians, scientists, engineers, industry, and investors will all be present at the forum. This year, NANS I3 will focus on Real World Data (RWD) and Real World Evidence (RWE).

Presentations will highlight insights and allow us to discuss outcome measures, trial design and statistics of designing studies. This session will explore what is being done in various markets across the globe to reduce cost and facilitate innovation in the field of neuromodulation.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Recognize how organizations support research by applying newly published guidance documents from the US FDA and EMA RWE to regulated product development.
  • Recognize how RWD can be used to aid in study design as well as a data source for clinical research.
  • Recognize the regulatory and clinical development context that have made RWE-enabled development strategies appealing.
Caesars Palace
Course Directors:

Nandan Lad, MD PhD

Adrian Hernandez, MD

Adam Aten, MPH MSc

Shervin Rahimpour, MD

Krishnan Chakravarthy, MD Phd